Please ensure Javascript is enabled for purposes of website accessibility

My Best Medical Marijuana Stock for 2021

By Eric Volkman - Jan 19, 2021 at 8:43PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This Florida-based company is a powerhouse in its market, and well positioned to expand in other states.

Nearly every cannabis company with big ambitions is involved in the medical marijuana segment, given its relatively high margins.

One company in particular, though, has more potential than the rest, according to veteran Motley Fool contributor Eric Volkman. He reveals his medical marijuana stock pick for 2021 in this conversation with Cannabis and Healthcare bureau chief Corinne Cardina Jurney during Motley Fool Live, recorded on Dec. 22.

Corinne Cardina: Let's talk about what you think the best medical marijuana stock is for 2021.

Eric Volkman: I like Trulieve (TCNNF 1.09%). Trulieve is, basically, a comprehensive medical stock that's based in Florida and it has made a lot of inroads into that market. I don't know if it's No. 1 in Florida, probably, but its got pretty strong market share into the double digits. It seems to constantly be opening dispensaries throughout the state.

Keep in mind Florida is a big state. Also, parts of it skew older in terms of demographics, the kind of demographic that would probably be more either inclined, or requiring of, medical marijuana and even while they are expensive and they are eager to build out their footprint, they haven't been careless about it, they haven't overpaid for assets that they bought. They're doing it in, what I would characterize, as a steady and sensible way, and that market still has room for growth.

Also the South isn't really a hotbed of marijuana legalization, that might be changing. We were discussing just before the Green Wave, which includes Mississippi which is not that far from Florida. That could maybe help trigger a mini-Green Wave in the South, and if so Trulieve might be poised to take advantage of that.

Neighboring places like Georgia, for example, could also be a pretty good market. Particularly in cities, in urban areas where demographics skew younger and I think there's more of a receptive audience and potential customer base for their services. So Trulieve is something that's worth keeping an eye on.

Of course, they're subject to the challenges and limitations of every marijuana company. But they are handling this pretty well and they're a little bit low key, a little bit under the radar. They haven't as far as I know, indicated any plans or any shift in strategy to build out from Florida, but I'm sure they're at least considering it. That's the stock worth watching, I think that's a stock that is going to do relatively well [in 2021].

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Trulieve Cannabis Stock Quote
Trulieve Cannabis
TCNNF
$13.02 (1.09%) $0.14

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
336%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.